XML 24 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:      
Net cash provided by operating activities (Note 2) $ 1,005,061 $ 1,174,339 $ 1,100,118
Cash flows from investing activities:      
Capital expenditures (206,294) (256,263) (259,974)
Origination of finance receivables (3,591,948) (3,664,495) (3,751,830)
Collections on finance receivables 3,228,311 3,175,031 3,136,885
Proceeds from finance receivables sold 0 312,571 0
Sales and redemptions of marketable securities 6,916 40,014 11,507
Acquisition of business 0 0 (59,910)
Other 547 411 7,474
Net cash used by investing activities (562,468) (392,731) (915,848)
Cash flows from financing activities:      
Proceeds from issuance of medium-term notes 893,668 1,193,396 595,386
Repayments of medium-term notes (800,000) (451,336) (610,331)
Proceeds from issuance of senior unsecured notes 0 0 740,385
Proceeds from securitization debt 0 0 1,195,668
Repayments of securitization debt (444,671) (665,400) (1,008,135)
Borrowings of asset-backed commercial paper 469,932 62,396 87,442
Repayments of asset-backed commercial paper (176,227) (71,500) (72,727)
Net increase (decrease) in credit facilities and unsecured commercial paper 212,809 (145,812) 469,473
Net change in restricted cash 8,458 43,495 11,410
Dividends paid (251,862) (252,321) (249,262)
Purchase of common stock for treasury (465,263) (465,341) (1,537,020)
Excess tax benefits from share-based payments 0 2,251 3,468
Issuance of common stock under employee stock option plans 11,353 15,782 20,179
Net cash used by financing activities (541,803) (734,390) (354,064)
Effect of exchange rate changes on cash and cash equivalents 26,747 (9,443) (14,677)
Net (decrease) increase in cash and cash equivalents (72,463) 37,775 (184,471)
Cash and cash equivalents:      
Cash and cash equivalents—beginning of period 759,984 722,209 906,680
Net (decrease) increase in cash and cash equivalents (72,463) 37,775 (184,471)
Cash and cash equivalents—end of period $ 687,521 $ 759,984 $ 722,209